Dr. Chris Smyth, president of ICON Biotech, discusses emerging trends in the biotech space.
Chris Smyth
Advertisement
Articles by Chris Smyth
Advertisement
Latest Updated Articles
Advertisement
Advertisement
Trending on PharmExec
1
Parabilis Medicines Raises $670 Million in Initial Public Offering
2
What 10 Years of Clinical Research Growth in Puerto Rico Have Taught Us
3
The Regulatory Landscape for Rare Pediatric Diseases
4
Pharmaceutical Executive Daily: Parabilis Medicines Prices Record-Breaking $670 Million IPO
5